Ex-Synageva team planning Kiniksa IPO

Kiniksa Pharmaceuticals Ltd. (Hamilton, Bermuda) filed on April 27 to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan, JMP Securities and Wedbush PacGrow.

Kiniksa Chairman and CEO Sanj Patel, President and COO Stephen Mahoney, CFO Chris Heberlig and Chief Legal Officer Thomas Beetham were all executives at Synageva BioPharma Corp., which Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) acquired in 2015 for about $9 billion (see BioCentury, May 18, 2015)...